<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
Blogs

CU Cancer Center News and Stories

Esophageal Cancer

Esophageal Cancer

How Endoscopic Therapy Cured Vic Padilla’s Precancerous Barrett’s Esophagus

Living with an external feeding tube and another tube in his neck to help him breathe?


Author Greg Glasgow | Publish Date June 03, 2024
Full Story

Lung Cancer    Liver Cancer    Pancreatic Cancer    Esophageal Cancer    Stomach Cancer

For Many Cancers, 5-Year Survival Rates at CU Cancer Center Exceed National Rates

A key yardstick used to evaluate success in cancer treatment shows that for many cancers, a higher percentage of people diagnosed at the University of Colorado Cancer Center have survived five years or more beyond their diagnoses than for the nation as a whole.


Author Mark Harden | Publish Date June 02, 2024
Full Story

Research    Esophageal Cancer    Pediatrics    Bioengineering

‘A Simple Idea That Could Make a Substantial Impact’: Can a String Replace Endoscopies for Esophageal Cancer, Other Disorders?

It looks pretty simple: A capsule the size of a jelly bean, attached to a string. And yet, it shows promise as an answer to a vexing question in the fight against esophageal cancer and other diseases of the upper digestive tract: How to spare patients from repeated endoscopies and biopsies.


Author Mark Harden | Publish Date April 26, 2024
Full Story

Patient Care    Esophageal Cancer    Clinical Trials

Mark Koebrich's Journey: From Television to Triumph Over Esophageal Cancer

Mark Koebrich's heartburn, a lifelong companion through nearly four decades in television, took a turn for the worse after retirement, prompting him to seek medical advice. His general practitioner referred him to UCHealth University of Colorado Hospital, where he met Sachin Wani, MD, the Endowed Chair of the Katy O. and Paul M. Esophageal and Gastric Center of Excellence. Koebrich was diagnosed with Barrett's esophagus with low-grade dysplasia, a precancerous condition, and was enrolled in the SURVENT trial, a groundbreaking study offering cutting-edge treatment options.


Author Cancer Center | Publish Date April 03, 2024
Full Story

Esophageal Cancer    Multidisciplinary Clinic   

Medical Director Named for CU Cancer Center’s Benign Esophageal/Gastric Clinic

The University of Colorado Cancer Center’s new Benign Esophageal and Gastric Multidisciplinary Clinic has its first medical director.


Author Mark Harden | Publish Date March 13, 2024
Full Story

Research    Esophageal Cancer

Endoscopic Surgery Device Wins Anschutz Acceleration Initiative Grant

A project to improve the effectiveness of endoscopic surgery, led by University of Colorado Cancer Center member Steven Edmundowicz, MD, is one of nine research endeavors to be awarded major funding from the Anschutz Acceleration Initiative (AAI).


Author Greg Glasgow | Publish Date February 23, 2024
Full Story

Research    COVID-19    Esophageal Cancer   

Exploring the COVID-19 Pandemic’s Effect on Barrett’s Esophagus and Esophageal Cancer Screening 

The COVID-19 pandemic had dramatic effects on all types of cancer screenings, from mammograms to colonoscopies. In the early days of the health crisis in spring 2020, screening numbers dropped dramatically as health care providers shifted their attention to caring for the seriously ill and fears of contracting the virus kept the general public away from hospitals, clinics, and other facilities.  


Author Greg Glasgow | Publish Date October 25, 2023
Full Story

Community    Esophageal Cancer

CU Cancer Center Member Opens Clinic for Benign Esophageal and Gastric Conditions 

University of Colorado Cancer Center member Sachin Wani, MD, inaugural director of the Katy O. and Paul M. Rady Esophageal and Gastric Center of Excellence, is behind a new clinic for people with benign, complex conditions of the foregut, including complicated reflux cases, refractory esophageal strictures, and motility disorders such as achalasia and gastroparesis. 


Author Greg Glasgow | Publish Date August 10, 2023
Full Story

Patient Care    Esophageal Cancer

Esophageal Cancer Patient Traveled From Indiana to Colorado to Receive Care at CU Cancer Center 

Nathan Hammond knew things were getting bad when his doctors had to put the feeding tube in. 


Author Greg Glasgow | Publish Date April 03, 2023
Full Story

Research    Philanthropy    Esophageal Cancer

Gift From Patient’s Family Funds Exploration of New Treatment for Esophageal Cancer 

Funding from the Paul R. O’Hara Seed Grant Fund at the University of Colorado Anschutz Medical Campus will allow CU Cancer Center member Akshay Chauhan, MD, to explore new methods of detecting and treating esophageal cancer


Author Greg Glasgow | Publish Date March 06, 2023
Full Story

Research    Patient Care    Awareness    Esophageal Cancer

Esophageal Cancer Patient Thriving and Optimistic after Multidisciplinary Care

Less than a year ago, Ken Herfert got a puppy and named her Bailey after the Colorado town where she was born.

This was a big deal for several reasons, including the responsibility of adopting a new family member, but perhaps the biggest was this: About six months after receiving a diagnosis of esophageal cancer in early 2018, Herfert’s oncologist in California told him he had maybe a year to live, maybe less.


Author Rachel Sauer | Publish Date August 16, 2022
Full Story

Research    Esophageal Cancer

Improving Detection of Esophageal Cancer in Patients with Barrett’s Esophagus

On a mission to increase early detection of esophageal cancer, University of Colorado (CU) Cancer Center member Sachin Wani, MD, is leading a study to see if a novel diagnostic platform can help endoscopists better identify the disease in patients with a condition called Barrett’s esophagus.


Author Greg Glasgow | Publish Date February 07, 2022
Full Story

Research    Patient Care    Esophageal Cancer    Surgical Oncology    Clinical Trials

Investigating a Better Treatment Sequence for Esophageal Cancer

Looking for better ways to treat patients with esophageal cancer, University of Colorado Cancer Center member Martin McCarter, MD, is investigating whether a new treatment sequence will result in better outcomes.


Author Greg Glasgow | Publish Date May 25, 2021
Full Story

Esophageal Cancer

What is Esophageal Cancer?

What is esophageal cancer?

Esophageal cancer is cancer that arises in the esophagus – a hollow, muscular tube that is about a foot long. It helps pass food and liquids from the back of the mouth to the stomach. The esophagus lies just behind the trachea and in front of the spine. Esophageal cancer begins in the cells that line the inside of the esophagus. 


Author Cancer Center | Publish Date April 24, 2019
Full Story

Esophageal Cancer

Rady family healing and helping others with CU Cancer Center

Katy Rady lost her brother, Paul, to cancer nearly four years ago. Katy and her husband, also named Paul, turned their grief into a mission to prevent other families from having to go through the same pain. That mission led to the Paul R. O’Hara II Esophagogastric Cancer Symposium.


Author Cancer Center | Publish Date April 24, 2019
Full Story

Patient Care    Faculty    Esophageal Cancer

Esophageal Cancer Care Crosses State Lines

When Tom Donahue came to UCHealth University of Colorado Hospital (UCH), University of Colorado Cancer Center’s clinical partner, he thought he had a pre-cancerous condition called Barrett’s Esophagus. But Donahue had a diagnosis of Barrett’s esophagus with high-grade dysplasia (precancerous cells) and an oncologist in Scottsbluff, Nebraska referred to him to UCH because he needed to see a specialist.  


Author Cancer Center | Publish Date February 05, 2019
Full Story

CU Cancer Center In the News

News Medical

Study shows effectiveness of treating pancreatic cancer patients with chemotherapy before surgery

news outletNews Medical
Publish DateJune 19, 2024

A new study led by University of Colorado Cancer Center member Marco Del Chiaro, MD, PhD, reveals that nearly 5% of pancreatic adenocarcinoma patients achieved a pathological complete response (pCR) after pre-surgical chemotherapy or chemoradiotherapy. This significant finding indicates that patients with pCR have a 63% five-year survival rate, compared to 30% for those without pCR, suggesting the potential for tailored treatments to improve outcomes.

Full Story
Cancer Network

Liso-cel May Show Benefit in Earlier Therapy Lines for Lymphoma Subgroups

news outletCancer Network
Publish DateJune 14, 2024

In a conversation at the 2024 European Hematology Association Congress, CU Cancer Center member Manali Kamdar, MD, discussed potential future research on lisocabtagene maraleucel (liso-cel; Breyanzi) for mantle cell lymphoma (MCL) and other lymphoma subgroups. She highlighted findings from the phase 1 TRANSCEND NHL 001 trial, noting improved efficacy and safety in patients with fewer prior therapies and non-refractory disease, suggesting liso-cel's utility in earlier treatment lines and specific lymphoma subgroups.

Full Story
Cancer Health

2024 Cancer Health 25: People Who Power Clinical Trials

news outletCancer Health
Publish DateJune 11, 2024

This year's Cancer Health 25 highlights the transformative power and promise of clinical trials. University of Colorado Cancer Center member Jessica McDermott, MD, MSCS, is leading clinical trials at both the CU Cancer Center and the Rocky Mountain Regional Veterans Affairs Medical Center. Additionally, she serves as the CU Cancer Center's deputy associate director for diversity and inclusion in clinical research.

Full Story
Cancer Network

Learning to “Aim High” Within Male-Dominated Fields in Public Health

news outletCancer Network
Publish DateJune 10, 2024

Cathy Bradley, PhD, deputy director of the University of Colorado Cancer Center and dean of the Colorado School of Public Health, is a trailblazer in health economics. At a Breaking Barriers: Women in Oncology discussion, she shared insights on overcoming challenges as a woman in a male-dominated field and discussed her research on the impact of employment on cancer patients' health insurance decisions.

Full Story